CA1049409A - Preparation of steroid-neomycin topical composition - Google Patents

Preparation of steroid-neomycin topical composition

Info

Publication number
CA1049409A
CA1049409A CA224,302A CA224302A CA1049409A CA 1049409 A CA1049409 A CA 1049409A CA 224302 A CA224302 A CA 224302A CA 1049409 A CA1049409 A CA 1049409A
Authority
CA
Canada
Prior art keywords
weight
neomycin
steroid
betamethasone
benzoate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA224,302A
Other languages
English (en)
French (fr)
Inventor
Martin L. Eichman
Susan C. Belsole
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of CA1049409A publication Critical patent/CA1049409A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA224,302A 1974-04-11 1975-04-10 Preparation of steroid-neomycin topical composition Expired CA1049409A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46025474A 1974-04-11 1974-04-11

Publications (1)

Publication Number Publication Date
CA1049409A true CA1049409A (en) 1979-02-27

Family

ID=23827960

Family Applications (1)

Application Number Title Priority Date Filing Date
CA224,302A Expired CA1049409A (en) 1974-04-11 1975-04-10 Preparation of steroid-neomycin topical composition

Country Status (7)

Country Link
JP (1) JPS535729B2 (de)
AU (1) AU7776275A (de)
CA (1) CA1049409A (de)
DE (2) DE2504615C3 (de)
DK (1) DK143537C (de)
FR (1) FR2267107B1 (de)
GB (1) GB1455552A (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984000111A1 (en) * 1982-06-24 1984-01-19 Robert Alan Smith Pharmaceutical gel composition

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489070A (en) * 1983-05-13 1984-12-18 Schering Corporation Betamethasone dipropionate cream
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
AU592065B2 (en) * 1984-10-09 1990-01-04 Dow Chemical Company, The Sustained release dosage form based on highly plasticized cellulose ether gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3614095A1 (de) * 1986-04-25 1987-10-29 Goedecke Ag Oxyalkylcellulose enthaltende gelzubereitung
ES2078256T3 (es) * 1990-04-05 1995-12-16 Knoll Ag Formula farmaceutica para uso topico que contiene diclofenaco sodico.
AU2000268609A1 (en) * 2000-09-14 2002-03-26 Robert Theiler Intraarticular agent for the treatment of osteoarthritis
PL2366408T3 (pl) * 2010-03-01 2013-01-31 Salvat Lab Sa Klarowne roztwory wodne acetonidu fluocinolonu do leczenia zapalenia uszu

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1017746B (de) * 1954-02-09 1957-10-17 Upjohn Co Verfahren zur Herstellung frei fliessender, nicht absetzender therapeutisch wirksamer Suspensionen
US3485915A (en) * 1966-04-22 1969-12-23 Revlon Thickened hydroxypropyl cellulose compositions
DE2015300A1 (de) * 1969-04-01 1970-10-29 Syntex Corp., Panania;PM örtliche, entzündungshemmende Präparate und Verfahren zu ihrer Verwendung
DK135267A (de) * 1971-02-25

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984000111A1 (en) * 1982-06-24 1984-01-19 Robert Alan Smith Pharmaceutical gel composition

Also Published As

Publication number Publication date
DE2515594A1 (de) 1975-10-30
JPS535729B2 (de) 1978-03-01
GB1455552A (en) 1976-11-17
DK147575A (de) 1975-10-12
DE2504615A1 (de) 1975-10-16
DK143537C (da) 1982-02-01
DK143537B (da) 1981-09-07
FR2267107B1 (de) 1978-07-28
AU7776275A (en) 1976-08-05
DE2504615B2 (de) 1977-07-14
DE2515594C3 (de) 1982-06-03
FR2267107A1 (de) 1975-11-07
JPS50132122A (de) 1975-10-20
DE2504615C3 (de) 1980-10-02
DE2515594B2 (de) 1978-12-07

Similar Documents

Publication Publication Date Title
US8232304B2 (en) Antifungal formulations
US5110809A (en) Antifungal gel formulations
EP0362270B2 (de) Steroide enthaltende flüssigkeit
US5002938A (en) Antifungal gel formulations
US5414011A (en) Preservative system for ophthalmic formulations
US4323558A (en) Topical trien containing pharmaceutical compositions and methods of use
US4607038A (en) Ophthalmic pranoprofen compositions
EP2420223B1 (de) Wässrige pharmazeutische Zusammensetzungen mit Borat-Polyol-Komplexen
US8546362B2 (en) Medicinal cream made using neomycin sulphate, betamethasone valerate, and chitosan, and a process to make the same
US4873265A (en) Anti-infective methods and compositions
US4013792A (en) Process for the production of base for topical steroids
CA1049409A (en) Preparation of steroid-neomycin topical composition
EP0988040B1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
JP2997202B2 (ja) 局所的眼科用途の為のトブラマイシンとステロイドの組合わせ
US4929619A (en) Anti-infective methods and compositions
RU2398587C2 (ru) Композиция
CA2053721A1 (en) Antiphlogistic analgesic cream composition
US4897404A (en) Anti-infective methods and compositions
NZ235054A (en) Gel formulation comprising imidazole antifungal agent and a 17-ester steroid anti-inflammatory agent with a co-solvent system and a gelling agent
US5879711A (en) Stable antiandrogenic gel composition
US4895857A (en) Anti-infective methods and compositions
US4895859A (en) Anti-infective methods and compositions
WO2003097070A1 (en) The pharmaceutical composition comprising a corticosteroid and an antiseptic
RU2223097C1 (ru) Комбинированное средство для лечения кожных заболеваний
CA1319105C (en) Antifungal gel formulations